ArticleSAGE open medicine2023

Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer.

Gen Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.